SP70 is a potential biomarker to identify gastric fundic gland neoplasms.
Rong-Kui LuoWen HuangLingli ChenYalan LiuLei XuXiaolei ZhangChen XuYingyong HouPublished in: World journal of surgical oncology (2022)
Down-expression of SP70 is a specific feature to fundic gland neoplasms including OGAs and GA-FGs. Therefore, SP70 can serve as a potential biomarker in the identification and differential diagnosis of fundic gland neoplasms.